306 related articles for article (PubMed ID: 16142909)
1. Lipid membranes modulate the structure of islet amyloid polypeptide.
Jayasinghe SA; Langen R
Biochemistry; 2005 Sep; 44(36):12113-9. PubMed ID: 16142909
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation.
Jaikaran ET; Nilsson MR; Clark A
Biochem J; 2004 Feb; 377(Pt 3):709-16. PubMed ID: 14565847
[TBL] [Abstract][Full Text] [Related]
3. Conserved and cooperative assembly of membrane-bound alpha-helical states of islet amyloid polypeptide.
Knight JD; Hebda JA; Miranker AD
Biochemistry; 2006 Aug; 45(31):9496-508. PubMed ID: 16878984
[TBL] [Abstract][Full Text] [Related]
4. Environmental factors differently affect human and rat IAPP: conformational preferences and membrane interactions of IAPP17-29 peptide derivatives.
Pappalardo G; Milardi D; Magrì A; Attanasio F; Impellizzeri G; La Rosa C; Grasso D; Rizzarelli E
Chemistry; 2007; 13(36):10204-15. PubMed ID: 17902185
[TBL] [Abstract][Full Text] [Related]
5. Amyloidogenic propensities and conformational properties of ProIAPP and IAPP in the presence of lipid bilayer membranes.
Jha S; Sellin D; Seidel R; Winter R
J Mol Biol; 2009 Jun; 389(5):907-20. PubMed ID: 19427320
[TBL] [Abstract][Full Text] [Related]
6. Suppression of IAPP fibrillation at anionic lipid membranes via IAPP-derived amyloid inhibitors and insulin.
Sellin D; Yan LM; Kapurniotu A; Winter R
Biophys Chem; 2010 Aug; 150(1-3):73-9. PubMed ID: 20153100
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.
Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE
J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784
[TBL] [Abstract][Full Text] [Related]
8. Islet amyloid polypeptide forms rigid lipid-protein amyloid fibrils on supported phospholipid bilayers.
Domanov YA; Kinnunen PK
J Mol Biol; 2008 Feb; 376(1):42-54. PubMed ID: 18155730
[TBL] [Abstract][Full Text] [Related]
9. Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity.
Kapurniotu A; Schmauder A; Tenidis K
J Mol Biol; 2002 Jan; 315(3):339-50. PubMed ID: 11786016
[TBL] [Abstract][Full Text] [Related]
10. Membrane permeabilization by Islet Amyloid Polypeptide.
Engel MF
Chem Phys Lipids; 2009 Jul; 160(1):1-10. PubMed ID: 19501206
[TBL] [Abstract][Full Text] [Related]
11. Amyloidogenicity and cytotoxicity of islet amyloid polypeptide.
Kapurniotu A
Biopolymers; 2001; 60(6):438-59. PubMed ID: 12209476
[TBL] [Abstract][Full Text] [Related]
12. Islet pathology of non-insulin-dependent diabetes mellitus (NIDDM).
Westermark P
Diabet Med; 1996 Sep; 13(9 Suppl 6):S46-8. PubMed ID: 8894481
[TBL] [Abstract][Full Text] [Related]
13. Islet amyloid polypeptide inserts into phospholipid monolayers as monomer.
Engel MF; Yigittop H; Elgersma RC; Rijkers DT; Liskamp RM; de Kruijff B; Höppener JW; Antoinette Killian J
J Mol Biol; 2006 Feb; 356(3):783-9. PubMed ID: 16403520
[TBL] [Abstract][Full Text] [Related]
14. Design of peptide-based inhibitors of human islet amyloid polypeptide fibrillogenesis.
Scrocchi LA; Chen Y; Waschuk S; Wang F; Cheung S; Darabie AA; McLaurin J; Fraser PE
J Mol Biol; 2002 May; 318(3):697-706. PubMed ID: 12054816
[TBL] [Abstract][Full Text] [Related]
15. Destabilization of human IAPP amyloid fibrils by proline mutations outside of the putative amyloidogenic domain: is there a critical amyloidogenic domain in human IAPP?
Abedini A; Raleigh DP
J Mol Biol; 2006 Jan; 355(2):274-81. PubMed ID: 16303136
[TBL] [Abstract][Full Text] [Related]
16. The role of His-18 in amyloid formation by human islet amyloid polypeptide.
Abedini A; Raleigh DP
Biochemistry; 2005 Dec; 44(49):16284-91. PubMed ID: 16331989
[TBL] [Abstract][Full Text] [Related]
17. Amide inequivalence in the fibrillar assembly of islet amyloid polypeptide.
Koo BW; Hebda JA; Miranker AD
Protein Eng Des Sel; 2008 Mar; 21(3):147-54. PubMed ID: 18299291
[TBL] [Abstract][Full Text] [Related]
18. Binding of islet amyloid polypeptide to supported lipid bilayers and amyloid aggregation at the membranes.
Sasahara K; Morigaki K; Okazaki T; Hamada D
Biochemistry; 2012 Sep; 51(35):6908-19. PubMed ID: 22876830
[TBL] [Abstract][Full Text] [Related]
19. Residual structure in islet amyloid polypeptide mediates its interactions with soluble insulin.
Wei L; Jiang P; Yau YH; Summer H; Shochat SG; Mu Y; Pervushin K
Biochemistry; 2009 Mar; 48(11):2368-76. PubMed ID: 19146426
[TBL] [Abstract][Full Text] [Related]
20. Impaired processing of human pro-islet amyloid polypeptide is not a causative factor for fibril formation or membrane damage in vitro.
Khemtémourian L; Lahoz Casarramona G; Suylen DP; Hackeng TM; Meeldijk JD; de Kruijff B; Höppener JW; Killian JA
Biochemistry; 2009 Nov; 48(46):10918-25. PubMed ID: 19817482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
